| Apr 15 2021 |
M&A Survives and Thrives in 2021: Dealmakers are Charged Up Heading into the New Year |
Foley & Lardner LLP |
| Apr 13 2021 |
Energy & Sustainability M&A Activity – April 2021 |
Mintz |
| Apr 9 2021 |
FTC Sues to Block Illumina/Grail Deal |
MoginRubin |
| Apr 8 2021 |
Competition Currents April 2021 | EU & UK |
Greenberg Traurig, LLP |
| Apr 8 2021 |
Health Care Transactions Trends in 2021 and Beyond |
K&L Gates LLP |
| Apr 7 2021 |
M&A Arbitration Clauses: "Watch-Outs" From A Litigator’s Perspective |
von Briesen & Roper, s.c. |
| Apr 6 2021 |
2021 Antitrust Outlook – A New Administration and State Activism Present Enforcement Uncertainty |
Foley & Lardner LLP |
| Apr 2 2021 |
New European Commission Guidance Acquisitions of Nascent Competitors on the Radar |
McDermott Will & Emery |
| Apr 1 2021 |
Is the European Commission Now Entitled to Review Non-Notifiable Transactions - Even After Closing? |
K&L Gates LLP |
| Mar 31 2021 |
Interest in SPACs—Special Purpose Acquisition Companies—is booming…and so is the risk of litigation. |
Cadwalader, Wickersham & Taft LLP |
| Mar 31 2021 |
The State of Competition in the U.S. Healthcare Industry |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 31 2021 |
New European Commission Guidance: Acquisitions of Nascent Competitors on the Radar |
McDermott Will & Emery |
| Mar 30 2021 |
Post-SPAC Technology Company Hit with Securities Class Action |
Proskauer Rose LLP |
| Mar 26 2021 |
Nevada Supreme Court: Inherent Fairness Standard Cannot Be Used To Rebut The Business Judgment Rule |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
| Mar 25 2021 |
Driving the Deal Podcast: Analyzing Shifts in Healthcare Private Equity Trends [PODCAST] |
McDermott Will & Emery |
| Mar 25 2021 |
The Ripples Behind the SPAC Wave |
Proskauer Rose LLP |
| Mar 25 2021 |
Merger Reviews Likely to Address More Expansive—and Possibly New—Theories of Harm |
Epstein Becker & Green, P.C. |
| Mar 22 2021 |
2020, 2021 and the EC/VC Industry – Review of the Past Year and Predictions for the Current One |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 22 2021 |
To Sell Or Not To Sell...Your Company: Five Things To Consider |
Goulston & Storrs |
| Mar 18 2021 |
Special Considerations in Video Game M&A Transactions |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 17 2021 |
The Potential Impact of COVID-19-Induced Volatility on Business Valuation in M&A and Bankruptcy Litigation |
Cornerstone Research |
| Mar 16 2021 |
Pharmaceutical Mergers: U.S. Antitrust Agencies Join Global Working Group |
Cadwalader, Wickersham & Taft LLP |
| Mar 11 2021 |
Credit Union Acquisitions of Banks — Considerations for Bank Boards of Directors |
Jones Walker LLP |
| Mar 9 2021 |
Hospital Merger Activity and Challenges: Two Conclude, One Merger Abandoned |
MoginRubin |
| Mar 8 2021 |
Energy & Sustainability M&A Activity – March 2021 |
Mintz |
| Mar 8 2021 |
DOJ Reaches Acquisition Settlement with Geisinger, Evangelical; Demonstrates Department’s Willingness to Challenge a Minority Investment |
Mintz |
| Mar 5 2021 |
CEO’s Role in Preparation of a Proxy Statement for a Merger Exposes CEO to Duty of Care Claims |
K&L Gates LLP |
| Mar 2 2021 |
Ready to Sell All or a Portion of your Management Company? – A Checklist of Asset Manager M&A Considerations |
Proskauer Rose LLP |
| Mar 1 2021 |
Antitrust Reform Effort Gets Some Shade |
MoginRubin |
| Mar 1 2021 |
CLERA or Murkier: Proposed Antitrust Legislation Raises Questions |
Proskauer Rose LLP |
| Feb 25 2021 |
Groundbreaking Fourth Circuit Decision Upholds Private Plaintiff’s Successful Effort to Unwind a Consummated Merger |
Faegre Drinker |
| Feb 25 2021 |
Vertical Deals in Healthcare: Key Antitrust Takeaways for Private Equity Firms |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 18 2021 |
English High Court Weighs in on MAC Clause in M&A Transaction |
Faegre Drinker |
| Feb 17 2021 |
M&A Pre-Flight Check: Avoiding Common Issues in Aerospace & Defense Acquisitions |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 17 2021 |
Driving the Deal Podcast Episode 8: Healthcare Private Equity Opportunities Under the New Administration |
McDermott Will & Emery |
